Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: diagnosed with stage I–III breast cancer, scheduled to receive adjuvant or neoadjuvant chemotherapy, received approval from a medical oncologist to participate in the trial
Exclusion criteria
Exclusion criteria: traumatic brain injury or concussion with residual symptoms, mobility issues that require a mobility aid or an injury/illness that would prohibit exercising, self-reported physical or cognitive condition that prevented women from participating independently
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FACIT-Fatigue scale Timepoint: total 4 weeks of protocol,outcome will be assessed at baseline and after 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Beck Anxiety Inventory Timepoint: which will be assessed at baseline and after 4 weeks;Beck Depression InventoryTimepoint: which will be assessed at baseline and after 4 weeks | — |
Countries
India
Contacts
KAHER Institute of Physiotherapy